Evidence map›Paper›PMID 34133758›Full record

ReviewJournal of cellular physiology2021

Interleukin-17-A multifaceted cytokine in viral infections.

Utkarsha Sahu, Debasis Biswas, Vijay Kumar Prajapati, Anirudh K Singh, Mukesh Samant, Prashant Khare

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cellular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Utkarsha SahuDepartment of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.ORCID 0000-0003-0664-0837
Debasis BiswasDepartment of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.ORCID 0000-0002-7557-3693
Vijay Kumar PrajapatiDepartment of Biochemistry, Central University of Rajasthan, Ajmer, Rajasthan, India.ORCID 0000-0001-6510-0596
Anirudh K SinghDepartment of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.ORCID 0000-0001-8625-4447
Mukesh SamantCell and Molecular Biology Laboratory, Department of Zoology, Kumaun University, Almora, Uttarakhand, India.ORCID 0000-0002-0154-2421
Prashant KhareDepartment of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.ORCID 0000-0001-5792-3082
All India Institute of Medical Sciences Bhopal · INCentral University of Rajasthan · INKumaun University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections are a major threat to the human population due to the lack of selective therapeutic measures. The morbidity and mortality reported worldwide are very alarming against viral pathogens. The proinflammatory environment is required for viral inhibition by initiating the host immune response. The host immune response fights these pathogens by secreting different cytokines. Interleukin-17 (IL-17) a proinflammatory cytokine mainly produced by T helper type 17 cells, plays a vital role in the regulation of host immune response against various pathogens, including viruses. However, dysregulated production of IL-17 induces chronic inflammation, autoimmune disorders, and may lead to cancer. Recent studies suggest that IL-17 is not only involved in the antiviral immune response but also promotes virus-mediated illnesses. In this review, we discuss the protective and pathogenic role of IL-17 against various viral infections. A detailed understanding of IL-17 during viral infections could contribute to improve therapeutic measures and enable the development of an efficient and safe IL-17 based immunotherapy.

Indexed as

AnimalsChronic DiseaseCytokinesHumansInflammationInterleukin-17Virus DiseasesCytokinesIL17A protein, humanInterleukin-17Anti-viral immune responseIL-17InflammationPathogenesisViral Infections

Identifiers

PMID34133758
PMCPMC8426678
OpenAlexW3172765043

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.